Jump to content
Sign in to follow this  
aussiebear

World Stock Markets Trading Discussion - Amiable adjustments

Rate this topic

Recommended Posts

A period of reflection for the early openers: Kiwis +0.7%, Aussies flat, Japan -0.6%, Sth Korea -0.2%.

In Aussie sectors, Consumer Discretionary a clear leader, +1.7% with Financials -0.6% down the most.

 

 

All Ords

xao_1d.png

http://www.abc.net.au/news/business/

Share this post


Link to post
Share on other sites

big.chart?nosettings=1&symb=AU%3AXAO&uf=

http://bigcharts.mar...com/default.asp

 

 

All Ords scraped together a +0.1% gain for the day.  Sectors ranged from Consumer Discretionary +1.4% down to Energy -0.6%.

Over in Asia, China -0.5%, Hong Kong +0.3%, Japan -1.1%, India currently +0.7%.


 

Marginally up in UK/Europe: FTSE flat, DAX +0.1%, CAC +0.4%.

 

 

 

big.chart?nosettings=1&symb=UK%3AUKX&uf=

 

 

 

big.chart?nosettings=1&symb=DX%3ADAX&uf=

 

 

big.chart?nosettings=1&symb=FR%3APX1&uf=

 

http://bigcharts.mar...com/default.asp

Share this post


Link to post
Share on other sites

Going to see straight up starting now until the close tomorrow as light volume gives way to higher prices.

Then, next week continuation as treasury supply is light.

Share this post


Link to post
Share on other sites

Going to see straight up starting now until the close tomorrow as light volume gives way to higher prices.

Then, next week continuation as treasury supply is light.

 

$37 billion in net new supply settling 5/31. So it's not light. 

 

Then $44 billion 6/15.  Supposed to be $17 billion in bill paydowns first 2 weeks of June. But we'll see. 

 

In fact, to have net new supply on a quarterly tax collection date is unusual.  

Share this post


Link to post
Share on other sites

I'm thinking 

 

 

burnt would have been better but the best I could do on short notice.

 

 

post-441-0-32744000-1527179233_thumb.jpg

Share this post


Link to post
Share on other sites

The toast thing is various daily charts. The weekly ones are a different story.  A perspective that can't be ignored.

Share this post


Link to post
Share on other sites

Out of REPH RECRO PHARMA INC at $6.0 for -$5.05. Intravenous (IV) meloxicam Phase 3 second endpoint was rejected by the FDA. REPH is probably dead in a year unless they get a major injection before mid-2019 in my opinion. FDA PDUFU's are always for very small positions in a Nassim Taleb style barbell strategy. But REPH passed the screening test as a high quality candidate. I don't find many that do.

Share this post


Link to post
Share on other sites
Guest
This topic is now closed to further replies.
Sign in to follow this  

  • Recently Browsing   0 members

    No registered users viewing this page.


Stock market portfolio giving you the runs? See Dr. Stool.

Take a subscribatory!
Download 
The Anals of Stock Proctology now!



The Daily Stool - Stock Market Message Board
Stool's Gold- Gold and Precious Metals Forum
Look Out Below Message Board

Support your local Stool Board.


The Al E. Greenspeuman designer line at Stoolmart. Get yours today! Click here now!



Old Stool Depository


The Wall Street Examiner
Subscribe to the Wall Street Examiner
Contact Us




Market Quotes are powered by Investing.com.
×